Lack of association between TRPV1 gene polymorphisms and risk of migraine chronification: a case-control study and meta-analysis
- PMID: 39105976
- PMCID: PMC11698790
- DOI: 10.1007/s10072-024-07724-0
Lack of association between TRPV1 gene polymorphisms and risk of migraine chronification: a case-control study and meta-analysis
Abstract
Objective: To confirm a previously reported association of TRPV1 rs8065080 with the risk of transformation from episodic (EM) to chronic migraine (CM) and to extend knowledge about the role of other TRPV1 single nucleotide polymorphisms (SNPs), we first investigated the impact of three TRPV1 SNPs (rs8065080, rs222747 and rs222749) on the risk of migraine chronification in a case-control study. A systematic review and meta-analysis were then conducted to summarize the accumulated findings.
Methods: Genotyping of the selected TRPV1 SNPs was performed using TaqMan real-time PCR in 167 EM and 182 CM participants. Crude and adjusted odds ratios with associated 95% confidence intervals were calculated in the log-additive, dominant, and recessive genetic models. A comprehensive literature search was performed in PubMed, Web of Knowledge, Cochrane Library, and OpenGrey until February 2024.
Results: In our case-control study, no association was found between TRPV1 SNPs and the risk of migraine chronification, both in the unadjusted logistic regression models and after adjustment for confounding clinical variables. The results of the meta-analysis with a total of 241 participants with EM and 223 with CM confirmed no association between TRPV1 SNPs and the risk of migraine chronification in any of the genetic models tested.
Conclusion: The results of the present case-control study and meta-analysis exclude a major role of TRPV1 rs8065080, rs222747, and rs222749 as risk factors for migraine chronification. However, further research is needed to investigate the gene-gene and gene-environment interactions of TRPV1 SNPs on the risk of transformation from episodic to chronic migraine.
Keywords: Chronic migraine; Episodic migraine; Meta-analysis; TRPV1, polymorphism.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethical statement: The study was performed in accordance with the guidelines of the Declaration of Helsinki. Authors obtained local ethics committee approval of the protocol (N°20180034973). Conflict of interest: The authors declare no competing interests.
Figures
References
-
- Steiner TJ, Stovner LJ (2023) Global epidemiology of migraine and its implications for public health and health policy. Nat Rev Neurol 19:109–117. 10.1038/s41582-022-00763-1 - PubMed
-
- Headache Classification Committee of the International Headache Society (IHS) (2018) The International classification of Headache disorders, 3rd edition. Cephalalgia 38(1):1–211. 10.1177/0333102417738202 - PubMed
-
- Goadsby PJ, Evers S (2020) International classification of Headache disorders - ICHD-4 alpha. Cephalalgia 40(9):887–888. 10.1177/0333102420919098 - PubMed
-
- Diener HC, Rizzoli P (2023) Chronic migraine and medication overuse. Handb Clin Neurol 198:187–200. 10.1016/B978-0-12-823356-6.00008-1 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical